Jafron Biomedical Co Ltd - Asset Resilience Ratio

Latest as of June 2026: 34.37%

Jafron Biomedical Co Ltd (300529) has an Asset Resilience Ratio of 34.37% as of June 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Jafron Biomedical Co Ltd (300529) working capital ratio to evaluate short-term liquidity relative to the company's equity base.

Liquid Assets

CN¥1.79 Billion

≈ $261.32 Million USD Cash + Short-term Investments

Total Assets

CN¥5.20 Billion

≈ $760.31 Million USD All company assets

Resilience Assessment

Very High

Financial Resilience Level

Asset Resilience Ratio Trend (2016–2025)

This chart shows how Jafron Biomedical Co Ltd's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see how large is Jafron Biomedical Co Ltd's balance sheet.

Liquid Assets Composition Over Time

This chart breaks down Jafron Biomedical Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Explore Jafron Biomedical Co Ltd (300529) investment intensity to see how much of total assets are deployed in long-term investments.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CN¥0.00	0%
Short-term Investments	CN¥1.79 Billion	34.37%
Total Liquid Assets	CN¥1.79 Billion	34.37%

Asset Resilience Insights

Very High Liquidity: Jafron Biomedical Co Ltd maintains exceptional liquid asset reserves at 34.37% of total assets.
This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
The company has significant short-term investments, indicating active treasury management.

Jafron Biomedical Co Ltd Industry Peers by Asset Resilience Ratio

Compare Jafron Biomedical Co Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Cochlear Ltd AU:COH	Medical Devices	9.76%
Jiangsu Yuyue Medical Equipment & Supply Co Ltd SHE:002223	Medical Devices	0.84%
Stratec SE XETRA:SBS	Medical Devices	0.29%
Shinhung KO:004080	Medical Devices	4.17%
DRTECH Corporation KQ:214680	Medical Devices	5.18%
Novacyt PA:ALNOV	Medical Devices	0.02%
Diagnostic Medical Systems SA PA:ALDMS	Medical Devices	1.48%
Implanet SA PA:ALIMP	Medical Devices	0.55%

Annual Asset Resilience Ratio for Jafron Biomedical Co Ltd (2016–2025)

The table below shows the annual Asset Resilience Ratio data for Jafron Biomedical Co Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-12-31	0.00%	CN¥61.82K ≈ $9.05K	CN¥5.41 Billion ≈ $791.50 Million	-11.02pp
2024-12-31	11.02%	CN¥593.07 Million ≈ $86.79 Million	CN¥5.38 Billion ≈ $787.77 Million	+7.90pp
2021-12-31	3.12%	CN¥150.01 Million ≈ $21.95 Million	CN¥4.81 Billion ≈ $703.87 Million	-4.57pp
2016-12-31	7.69%	CN¥100.00 Million ≈ $14.63 Million	CN¥1.30 Billion ≈ $190.21 Million	--

pp = percentage points

About Jafron Biomedical Co Ltd

SHE:300529 China Medical Devices

Market Cap

$1.75 Billion

CN¥11.99 Billion CNY

Market Cap Rank

#6677 Global

#1365 in China

Share Price

CN¥15.01

Change (1 day)

-0.13%

52-Week Range

CN¥14.86 - CN¥22.41

All Time High

CN¥96.12